ClinicalTrials.gg
CompletedNCT07839429Updated Oct 1, 2026

Effect of mHealth Intervention on Oral Health-Related Quality of Life Among Adult Patients With Chronic Systemic Diseases

An interventional study of mHealth Oral Health Education Intervention and Printed Oral Health Education Leaflet in Hereditary Blood Disorders, Cardiovascular Diseases and Chronic Kidney Disease, sponsored by King Faisal University. Completed at 4 sites in Saudi Arabia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-01.

Sponsored by King Faisal University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Dec 2025, registered Sep 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
206
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluated whether an mHealth oral health education intervention could improve oral health-related quality of life among adults with chronic systemic diseases registered in specialized disease centers in Al-Ahsa, Saudi Arabia. Adults with type 1 diabetes mellitus, cardiovascular disease, chronic kidney disease, or hereditary blood disorders were included.

Participants were assigned to either an intervention group or a control group. Both groups continued to receive routine care. The control group received a standardized printed oral health education leaflet, while the intervention group received an mHealth oral health education program consisting of five educational videos covering toothbrush and fluoride toothpaste selection, toothbrushing technique, dental flossing, tongue cleaning, and water flosser use. The educational materials were delivered electronically through a secure web-based platform, with links sent through WhatsApp at regular intervals during the 3-month intervention period.

Oral health-related quality of life was assessed using the validated Arabic version of the 14-item Oral Health Impact Profile (OHIP-14) at baseline, 1 month, and 3 months. The main hypothesis was that participants receiving the mHealth intervention would show greater improvement in oral health-related quality of life over the 3-month study period compared with participants receiving the control condition.

Read the detailed description

This pragmatic quasi-experimental study was conducted among adult patients registered in four specialized disease centers in Al-Ahsa, Saudi Arabia: the Endocrinology and Diabetes Center, Prince Sultan Center for Cardiac Diseases and Surgery, Al-Jaber Kidney Center, and Hereditary Blood Diseases Center. The study population included adults with type 1 diabetes mellitus, cardiovascular disease, chronic kidney disease, or hereditary blood disorders.

Eligible participants provided electronic informed consent before participation. Following baseline assessment, participants were assigned to parallel intervention and control groups. The intervention lasted 3 months, with assessments conducted at baseline (T0), 1 month (T1), and 3 months (T2).

Participants in both groups continued their routine health care. The control group received a standardized printed oral health education leaflet containing recommendations for daily home oral care. In addition to routine care, the intervention group received five Arabic educational videos addressing toothbrush and fluoride toothpaste selection, toothbrushing technique, dental flossing, tongue cleaning, and water flosser use. The intervention was delivered through a secure web-based platform, and access links were sent through WhatsApp. The educational package was re-sent every 2 weeks during the intervention period to reinforce exposure to the educational content.

Oral health-related quality of life was measured using the validated Arabic version of the 14-item Oral Health Impact Profile (OHIP-14). Assessments were completed at baseline, 1 month, and 3 months. The principal comparison focused on differences between the intervention and control groups in change in total OHIP-14 score from baseline to the 3-month assessment. Additional analyses examined OHIP-14 over the study period and its relationship with selected participant characteristics.

02

Conditions studied

  • Hereditary Blood Disorders
  • Cardiovascular Diseases
  • Chronic Kidney Disease
  • Diabete Mellitus

Keywords

  • Oral Health-Related Quality of Life
  • Oral Health Impact Profile
  • mHealth
  • Saudi Arabia
  • Chronic Systemic Diseases
  • Oral Health Education
03

In context

Cardiovascular Diseases

5,368 studies on the registry are indexed under Cardiovascular Diseases; 939 are open to participants now.

This study's enrollment of 206 is above the median of 100 across 3,084 interventional studies indexed under Cardiovascular Diseases.

Browse Cardiovascular Diseases studies →

Lead sponsor

King Faisal University is the lead sponsor of 15 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years or older.
  • Registered at one of the participating specialized disease centers in Al-Ahsa, Saudi Arabia.
  • Physician-confirmed diagnosis of type 1 diabetes mellitus, cardiovascular disease, chronic kidney disease, or a hereditary blood disorder.
  • Medically stable at the time of enrollment.
  • Has access to a smartphone and the internet.
  • Able to understand Arabic.
  • Provides electronic .
  • Willing and able to participate for the 3-month study period.

Exclusion criteria

Exclusion Criteria:

  • Unable to use a smartphone or access the digital intervention.
  • Cognitive or psychiatric impairment that could interfere with participation or completion of study assessments.
  • Severe disability that prevents participation in the study procedures.
  • Completely edentulous.
  • Pregnant at the time of enrollment.
  • Currently enrolled in another oral health intervention study.
  • Planning to relocate during the 3-month study period.
  • Medically unstable or considered unsuitable for participation based on clinical assessment.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
206 participants (actual)

Study arms

  • Experimental
    mHealth Oral Health Education Intervention

    Participants received routine care, including the standardized printed oral health education leaflet provided during routine visits, plus a 3-month mHealth oral health education intervention consisting of five Arabic educational videos.

    Behavioral: mHealth Oral Health Education Intervention · Behavioral: Printed Oral Health Education Leaflet

  • Active comparator
    Control

    Participants received routine care, including the standardized printed oral health education leaflet provided during routine visits, but did not receive the mHealth educational videos.

    Behavioral: Printed Oral Health Education Leaflet

Interventions

  • BehavioralmHealth Oral Health Education Intervention

    A 3-month Arabic mHealth oral health education intervention consisting of five educational videos covering toothbrush and fluoride toothpaste selection, toothbrushing technique, dental flossing, tongue cleaning, and water flosser use. The videos were delivered through a secure web-based platform, with access links sent via WhatsApp. The complete educational package was provided at baseline and re-sent every 2 weeks through week 10. Participants continued to receive their usual care throughout the study.

  • BehavioralPrinted Oral Health Education Leaflet

    A standardized printed oral health education leaflet providing recommendations for daily home oral care, provided as part of routine care.

06

What researchers measure

Primary outcomes

  1. Change in Total Oral Health Impact Profile-14 (OHIP-14) Score From Baseline to 3 Months

    Oral health-related quality of life was assessed using the validated Arabic version of the 14-item Oral Health Impact Profile (OHIP-14). Each item is scored from 0 to 4, yielding a total score ranging from 0 to 56. Higher scores indicate poorer oral health-related quality of life. The outcome is the change in total OHIP-14 score from baseline to 3 months, compared between the intervention and control groups.

    Time frame: Baseline and 3 months

Secondary outcomes

  1. Change in Total Oral Health Impact Profile-14 (OHIP-14) Score From Baseline to 1 Month

    Oral health-related quality of life was assessed using the validated Arabic version of the 14-item Oral Health Impact Profile (OHIP-14). Each item is scored from 0 to 4, yielding a total score ranging from 0 to 56. Higher scores indicate poorer oral health-related quality of life. This outcome assesses the change in total OHIP-14 score from baseline to 1 month and compares the change between the intervention and control groups.

    Time frame: Baseline and 1 month

  2. Total Oral Health Impact Profile-14 (OHIP-14) Score Trajectory Across the Study Period

    Oral health-related quality of life was assessed using the validated Arabic version of the 14-item Oral Health Impact Profile (OHIP-14) at baseline, 1 month, and 3 months. Total scores range from 0 to 56, with higher scores indicating poorer oral health-related quality of life. This outcome evaluates changes in total OHIP-14 score across the three assessment time points.

    Time frame: Baseline, 1 month, and 3 months

  3. Seven Domain Scores of the Oral Health Impact Profile-14 (OHIP-14)

    The seven domains of the Arabic OHIP-14 were assessed separately: functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability, and handicap. Each domain consists of two items scored from 0 to 4, yielding a domain score ranging from 0 to 8. Higher domain scores indicate a greater negative impact on oral health-related quality of life. Domain scores were assessed separately at baseline, 1 month, and 3 months to evaluate changes over the study period.

    Time frame: Baseline, 1 month, and 3 months

07

Study locations

4 sites
  • Al Jabr Kidney Center
    Hasa, Eastern Province 36411, Saudi Arabia
  • Endocrine and Diabetes Center
    Hasa, Eastern Province 36411, Saudi Arabia
  • Hereditary Blood Disease Center
    Al Mubarraz, 36422, Saudi Arabia
  • Prince Sultan Cardiac Center
    Ḩasā, 36411, Saudi Arabia
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared because data sharing was not included in the approved study protocol or informed consent. Aggregated study findings will be reported in scientific publications.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2025 to primary completion in May 2026, 5 months.

Of 1,077 non-industry interventional studies with no phase under Cardiovascular Diseases, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's 5 months is below that.

Counting every sponsor, half of 1,216 studies reached it within 26 months; a quarter within 12 and three quarters within 49.

Cardiovascular Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 18, 2026
First posted
Sep 24, 2026
StartActual
Dec 7, 2025
Primary completionActual
May 30, 2026
CompletionActual
May 30, 2026
Last update
Oct 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: index terms and conditions
1 update, last Oct 1, 2026
Show all 1 update
  1. Oct 1, 2026
    Minor edits only
    + 2 other changes: index terms and conditions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07839429
Lead sponsor
King Faisal University
Responsible party
Sponsor
First posted
Sep 24, 2026
Start date
Dec 7, 2025
Primary completion
May 30, 2026
Completion
May 30, 2026
Last update
Oct 1, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion